Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 7
2004 3
2005 7
2006 4
2007 5
2008 4
2009 11
2010 14
2011 17
2012 8
2013 12
2014 12
2015 9
2016 10
2017 5
2018 14
2019 9
2020 18
2021 18
2022 18
2023 7
2024 3
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

185 results

Results by year

Filters applied: . Clear all
Page 1
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial.
Horwitz S, O'Connor OA, Pro B, Illidge T, Fanale M, Advani R, Bartlett NL, Christensen JH, Morschhauser F, Domingo-Domenech E, Rossi G, Kim WS, Feldman T, Lennard A, Belada D, Illés Á, Tobinai K, Tsukasaki K, Yeh SP, Shustov A, Hüttmann A, Savage KJ, Yuen S, Iyer S, Zinzani PL, Hua Z, Little M, Rao S, Woolery J, Manley T, Trümper L; ECHELON-2 Study Group. Horwitz S, et al. Lancet. 2019 Jan 19;393(10168):229-240. doi: 10.1016/S0140-6736(18)32984-2. Epub 2018 Dec 4. Lancet. 2019. PMID: 30522922 Free PMC article. Clinical Trial.
Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial.
Dimopoulos MA, Terpos E, Boccadoro M, Delimpasi S, Beksac M, Katodritou E, Moreau P, Baldini L, Symeonidis A, Bila J, Oriol A, Mateos MV, Einsele H, Orfanidis I, Ahmadi T, Ukropec J, Kampfenkel T, Schecter JM, Qiu Y, Amin H, Vermeulen J, Carson R, Sonneveld P; APOLLO Trial Investigators. Dimopoulos MA, et al. Among authors: baldini l. Lancet Oncol. 2021 Jun;22(6):801-812. doi: 10.1016/S1470-2045(21)00128-5. Lancet Oncol. 2021. PMID: 34087126 Clinical Trial.
Subcutaneous daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma (APOLLO): extended follow up of an open-label, randomised, multicentre, phase 3 trial.
Dimopoulos MA, Terpos E, Boccadoro M, Delimpasi S, Beksac M, Katodritou E, Moreau P, Baldini L, Symeonidis A, Bila J, Oriol A, Mateos MV, Einsele H, Orfanidis I, Kampfenkel T, Liu W, Wang J, Kosh M, Tran N, Carson R, Sonneveld P. Dimopoulos MA, et al. Among authors: baldini l. Lancet Haematol. 2023 Oct;10(10):e813-e824. doi: 10.1016/S2352-3026(23)00218-1. Lancet Haematol. 2023. PMID: 37793772 Clinical Trial.
Polarized x-rays from a magnetar.
Taverna R, Turolla R, Muleri F, Heyl J, Zane S, Baldini L, González-Caniulef D, Bachetti M, Rankin J, Caiazzo I, Di Lalla N, Doroshenko V, Errando M, Gau E, Kırmızıbayrak D, Krawczynski H, Negro M, Ng M, Omodei N, Possenti A, Tamagawa T, Uchiyama K, Weisskopf MC, Agudo I, Antonelli LA, Baumgartner WH, Bellazzini R, Bianchi S, Bongiorno SD, Bonino R, Brez A, Bucciantini N, Capitanio F, Castellano S, Cavazzuti E, Ciprini S, Costa E, De Rosa A, Del Monte E, Di Gesu L, Di Marco A, Donnarumma I, Dovčiak M, Ehlert SR, Enoto T, Evangelista Y, Fabiani S, Ferrazzoli R, Garcia JA, Gunji S, Hayashida K, Iwakiri W, Jorstad SG, Karas V, Kitaguchi T, Kolodziejczak JJ, La Monaca F, Latronico L, Liodakis I, Maldera S, Manfreda A, Marin F, Marinucci A, Marscher AP, Marshall HL, Matt G, Mitsuishi I, Mizuno T, Ng SC, O'Dell SL, Oppedisano C, Papitto A, Pavlov GG, Peirson AL, Perri M, Pesce-Rollins M, Pilia M, Poutanen J, Puccetti S, Ramsey BD, Ratheesh A, Romani RW, Sgrò C, Slane P, Soffitta P, Spandre G, Tavecchio F, Tawara Y, Tennant AF, Thomas NE, Tombesi F, Trois A, Tsygankov SS, Vink J, Wu K, Xie F. Taverna R, et al. Among authors: baldini l. Science. 2022 Nov 11;378(6620):646-650. doi: 10.1126/science.add0080. Epub 2022 Nov 3. Science. 2022. PMID: 36356124
What Is New in the Treatment of Smoldering Multiple Myeloma?
Bolli N, Sgherza N, Curci P, Rizzi R, Strafella V, Delia M, Gagliardi VP, Neri A, Baldini L, Albano F, Musto P. Bolli N, et al. Among authors: baldini l. J Clin Med. 2021 Jan 22;10(3):421. doi: 10.3390/jcm10030421. J Clin Med. 2021. PMID: 33499196 Free PMC article. Review.
Polarized blazar X-rays imply particle acceleration in shocks.
Liodakis I, Marscher AP, Agudo I, Berdyugin AV, Bernardos MI, Bonnoli G, Borman GA, Casadio C, Casanova VC, Cavazzuti E, Rodriguez Cavero N, Di Gesu L, Di Lalla N, Donnarumma I, Ehlert SR, Errando M, Escudero J, Garcı A-Comas M, Agı S-González B, Husillos C, Jormanainen J, Jorstad SG, Kagitani M, Kopatskaya EN, Kravtsov V, Krawczynski H, Lindfors E, Larionova EG, Madejski GM, Marin F, Marchini A, Marshall HL, Morozova DA, Massaro F, Masiero JR, Mawet D, Middei R, Millar-Blanchaer MA, Myserlis I, Negro M, Nilsson K, O'Dell SL, Omodei N, Pacciani L, Paggi A, Panopoulou GV, Peirson AL, Perri M, Petrucci PO, Poutanen J, Puccetti S, Romani RW, Sakanoi T, Savchenko SS, Sota A, Tavecchio F, Tinyanont S, Vasilyev AA, Weaver ZR, Zhovtan AV, Antonelli LA, Bachetti M, Baldini L, Baumgartner WH, Bellazzini R, Bianchi S, Bongiorno SD, Bonino R, Brez A, Bucciantini N, Capitanio F, Castellano S, Ciprini S, Costa E, De Rosa A, Del Monte E, Di Marco A, Doroshenko V, Dovčiak M, Enoto T, Evangelista Y, Fabiani S, Ferrazzoli R, Garcia JA, Gunji S, Hayashida K, Heyl J, Iwakiri W, Karas V, Kitaguchi T, Kolodziejczak JJ, La Monaca F, Latronico L, Maldera S, Manfreda A, Marinucci A, Matt G, Mitsui… See abstract for full author list ➔ Liodakis I, et al. Among authors: baldini l. Nature. 2022 Nov;611(7937):677-681. doi: 10.1038/s41586-022-05338-0. Epub 2022 Nov 23. Nature. 2022. PMID: 36418451 Free PMC article.
Pathological and genomic features of myeloproliferative neoplasms associated with splanchnic vein thrombosis in a single-center cohort.
Cattaneo D, Bucelli C, Marchetti A, Lionetti M, Fermo E, Bellani V, De Magistris C, Maeda A, Marella A, Primignani M, Consonni D, Gianelli U, Neri A, Baldini L, Bolli N, Iurlo A. Cattaneo D, et al. Among authors: baldini l. Ann Hematol. 2023 Jun;102(6):1409-1420. doi: 10.1007/s00277-023-05217-2. Epub 2023 Apr 20. Ann Hematol. 2023. PMID: 37079068 Review.
185 results